Arcturus Therapeutics Holdings (ARCT) Change in Account Payables: 2018-2025
Historic Change in Account Payables for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Sep 2025 value amounting to -$5.0 million.
- Arcturus Therapeutics Holdings' Change in Account Payables fell 33.68% to -$5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.6 million, marking a year-over-year increase of 42.24%. This contributed to the annual value of $1.9 million for FY2024, which is 185.57% up from last year.
- As of Q3 2025, Arcturus Therapeutics Holdings' Change in Account Payables stood at -$5.0 million, which was down 213.52% from $4.4 million recorded in Q2 2025.
- Arcturus Therapeutics Holdings' 5-year Change in Account Payables high stood at $11.8 million for Q1 2023, and its period low was -$12.7 million during Q4 2023.
- Moreover, its 3-year median value for Change in Account Payables was -$1.0 million (2025), whereas its average is -$176,273.
- In the last 5 years, Arcturus Therapeutics Holdings' Change in Account Payables plummeted by 569.28% in 2022 and then spiked by 26,890.91% in 2023.
- Arcturus Therapeutics Holdings' Change in Account Payables (Quarterly) stood at $1.8 million in 2021, then plummeted by 569.28% to -$8.4 million in 2022, then crashed by 50.76% to -$12.7 million in 2023, then surged by 76.94% to -$2.9 million in 2024, then plummeted by 33.68% to -$5.0 million in 2025.
- Its Change in Account Payables stands at -$5.0 million for Q3 2025, versus $4.4 million for Q2 2025 and -$1.0 million for Q1 2025.